Skip to main content
. Author manuscript; available in PMC: 2014 Dec 31.
Published in final edited form as: Am J Transplant. 2014 May 19;14(6):1249–1258. doi: 10.1111/ajt.12725

Table 1.

Cell-signaling pathways controlled by cytomegalovirus

Primary pathway Virus-derived facilitator (s) Drug Reference
AMPK Unknown Compound C, AICAR, ST0–609 (4,5)
mTOR IE72, IE86, UL38 Sirolimus, everolimus, rapamycin, torin (912)
CDKs Unknown Roscovitine (21)
PDGFR-α gB (?) Imatinib mesylate, IMC-3G3, (2)
PI3K gB LY294002 (23)
NF-κB gB/gH, UL76, UL144, IE86 BAY-11–7082, dexamethasone, lactacystin (2528,35,36)
RAS/RAF/MEK1/2 IE86, IE72 Sorafenib, U0126, PD98059, FHPI (3841)
UPR/proteasome degradation US2, US11, pp71, UL38 Clotrimazole (51)
WNT Unknown Monensin, nigericin, salinomycin (56)

AMPK, AMP-activated protein kinase; CDKs, cyclin-dependent kinases; mTOR, mammalian target of rapamycin; NF-κB, nuclear factor kappa beta; PDGFR-α, platelet-derived growth factor receptor-α; PI3K, phosphatidylinositol-3-kinase; UPR, unfolded protein response.